标题
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
作者
关键词
-
出版物
ACS Medicinal Chemistry Letters
Volume 13, Issue 1, Pages 92-98
出版商
American Chemical Society (ACS)
发表日期
2021-12-07
DOI
10.1021/acsmedchemlett.1c00527
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study
- (2021) Christoph U. Correll et al. CNS SPECTRUMS
- Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856
- (2021) Veronica Begni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans
- (2021) Seth C. Hopkins et al. Translational Psychiatry
- Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs
- (2021) Pramod C. Nair et al. MOLECULAR PSYCHIATRY
- Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
- (2020) Michelle Kokkinou et al. MOLECULAR PSYCHIATRY
- A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
- (2020) Kenneth S. Koblan et al. NEW ENGLAND JOURNAL OF MEDICINE
- GPCRdb in 2021: integrating GPCR sequence, structure and function
- (2020) Albert J Kooistra et al. NUCLEIC ACIDS RESEARCH
- SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION
- (2019) Nina Dedic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- TAAR Agonists
- (2019) Zhengrong Xu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present)
- (2019) Michele Tonelli et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists
- (2018) Sara Guariento et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Trace Amines and Their Receptors
- (2018) Raul R. Gainetdinov et al. PHARMACOLOGICAL REVIEWS
- The Case for TAAR1 as a Modulator of Central Nervous System Function
- (2018) Grazia Rutigliano et al. Frontiers in Pharmacology
- Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders
- (2018) Sherri L. Christian et al. Frontiers in Pharmacology
- Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies
- (2017) Michele Tonelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers
- (2015) Anja Harmeier et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
- (2015) Stefano Espinoza et al. NEUROPHARMACOLOGY
- TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
- (2015) Stefano Espinoza et al. NEUROPSYCHOPHARMACOLOGY
- Discovery of trace amine-associated receptor 1 ligands by molecular docking screening against a homology model
- (2015) V. M. Lam et al. MedChemComm
- Further Insights Into the Pharmacology of the Human Trace Amine-Associated Receptors: Discovery of Novel Ligands for TAAR1 by a Virtual Screening Approach
- (2014) Elena Cichero et al. Chemical Biology & Drug Design
- Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
- (2014) D. Leo et al. NEUROPHARMACOLOGY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
- (2012) Florent G. Revel et al. BIOLOGICAL PSYCHIATRY
- Insights into the Structure and Pharmacology of the Human Trace Amine-Associated Receptor 1 (hTAAR1): Homology Modelling and Docking Studies
- (2012) Elena Cichero et al. Chemical Biology & Drug Design
- A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
- (2012) F G Revel et al. MOLECULAR PSYCHIATRY
- Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
- (2012) Florent G Revel et al. NEUROPSYCHOPHARMACOLOGY
- FRED Pose Prediction and Virtual Screening Accuracy
- (2011) Mark McGann Journal of Chemical Information and Modeling
- TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
- (2011) F. G. Revel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Molecular Basis of Species-Specific Ligand Activation of Trace Amine-Associated Receptor 1 (TAAR1)
- (2009) Edwin S. Tan et al. ACS Chemical Biology
- The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
- (2009) A. Bradaia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search